
Does the use of Rabsig-L lead to increased risk of fractures?
Nov 4, 2023
Does the use of Rabsig-L lead to increased risk of fractures?
Numerous studies conducted on adult individuals have brought forth a significant possibility that the administration of RabsigL treatment might potentially elevate the chances of sustaining osteoporosisrelated fractures in crucial areas such as the hip wrist or spine This alarming risk of fracture occurrence has been predominantly observed among patients who have been subjected to high doses of RabsigL The term high dose denotes the consumption of multiple daily doses and the continuation of therapy for an extended period typically exceeding a year These findings stemming from diverse research investigations in adults indicate a concerning correlation between RabsigL usage and an increased vulnerability to debilitating fractures in critical anatomical sites It is important to highlight that the risk is particularly escalated when individuals are exposed to higher concentrations of the medication over prolonged durations Therefore healthcare providers need to exercise extra caution and closely monitor patients receiving RabsigL treatment in order to mitigate the potential risks associated with osteoporosisrelated fractures
Medicines
For information purposes only. Consult a doctor before taking any medicines.
₹130₹260
₹237₹263
₹189₹210
₹144₹160
₹328₹365
₹146₹162
₹255₹283
₹111₹123
₹135₹150